Dietary Advanced Glycation End Products and Risk of Overall and Cause-Specific Mortality: Results from the Golestan Cohort Study
International Journal of Environmental Research and Public Health · 2023
DOI: 10.3390/ijerph20053788 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Environmental Research and Public Health, 2023. Verfasst von Elham Hosseini und 13 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition and Food Security Research Center, Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sc…. Hauptthemen laut MEDLINE: Dietary Advanced Glycation End Products, Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Cancer Research UK, Tehran University of Medical Sciences.
Abstract (Originalsprache)
Controversy exists regarding the association of dietary advanced glycation end products (dAGEs) with the risk of disease outcomes and mortality. We aimed to examine, prospectively, the association between dAGEs intake and the risk of overall and cause-specific mortality in the Golestan Cohort Study. The cohort was conducted between 2004 and 2008 in Golestan Province (Iran) recruiting 50,045 participants aged 40–75 years. Assessment of dietary intake over the last year was performed at baseline using a 116-item food frequency questionnaire. The dAGEs values for each individual were calculated based on published databases of AGE values of various food items. The main outcome was overall mortality at the time of follow-up (13.5 years). Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall and cause-specific mortality were estimated according to the dAGEs quintiles. During 656, 532 person-years of follow-up, 5406 deaths in men and 4722 deaths in women were reported. Participants at the highest quintile of dAGE had a lower risk of overall mortality (HR: 0.89, 95% CI: 0.84, 0.95), CVD mortality (HR: 0.89, 95% CI: 0.84, 0.95), and death from other causes (HR: 0.89, 95% CI: 0.84, 0.95) compared to those in the first quintile after adjusting for confounders. We found no association of dAGEs with risk of mortality from cancer (all), respiratory and infectious diseases, and injuries. Our findings do not confirm a positive association between dAGEs and the risk of mortality in Iranian adults. There is still no agreement among studies investigating dAGEs and their health-related aspects. So, further high-quality studies are required to clarify this association.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutrition and Food Security Research Center, Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
- Liver and Pancreaticobiliary Disease Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran 14117-13135, Iran.
- Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran 14117-13135, Iran.
- Golestan Research Center of Gasteroenterology and Hepatology (GRCGH), Golestan University of Medical Sciences, Gorgan 49178-67439, Iran.
- Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
- Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
ORCID-Profile: Elham Hosseini, Paolo Boffetta, Azita Hekmatdoost
Förderung
- World Health Organization
- Cancer Research UK
- Tehran University of Medical Sciences
- Intramural Research Program of the NCI, National Institutes of Health
Zitieren
APA
Hosseini, E., Mokhtari, Z., Poustchi, H., Khoshnia, M., Dawsey, S. M., Boffetta, P., Abnet, C. C., Kamangar, F., Etemadi, A., Pourshams, A., Sharafkhah, M., Brennan, P., Malekzadeh, R., & Hekmatdoost, A. (2023). Dietary Advanced Glycation End Products and Risk of Overall and Cause-Specific Mortality: Results from the Golestan Cohort Study. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph20053788
Vancouver
Hosseini E, Mokhtari Z, Poustchi H, Khoshnia M, Dawsey SM, Boffetta P, et al. Dietary Advanced Glycation End Products and Risk of Overall and Cause-Specific Mortality: Results from the Golestan Cohort Study. International Journal of Environmental Research and Public Health. 2023. doi:10.3390/ijerph20053788
BibTeX
@article{Hosseini2023,
author = {Hosseini, Elham and Mokhtari, Zeinab and Poustchi, Hossein and Khoshnia, Masoud and Dawsey, Sanford M and Boffetta, Paolo and Abnet, Christian C and Kamangar, Farin and Etemadi, Arash and Pourshams, Akram and Sharafkhah, Maryam and Brennan, Paul and Malekzadeh, Reza and Hekmatdoost, Azita},
title = {Dietary Advanced Glycation End Products and Risk of Overall and Cause-Specific Mortality: Results from the Golestan Cohort Study},
journal = {International Journal of Environmental Research and Public Health},
year = {2023},
doi = {10.3390/ijerph20053788}
}
EUVIMED